So far, numerous molecules and biomolecules have been evaluated for tumor targeting
purposes for radionuclide-based imaging and therapy modalities. Due to the high affinity …

Purpose This review aims to provide a comprehensive overview of the latest literature on
personalized lung cancer management using different ligands and radionuclide-based …

Reconstituted high-density lipoproteins (rHDLs) can transport and specifically release drugs
and imaging agents, mediated by the Scavenger Receptor Type B1 (SR-B1) present in a …

Cell penetrating peptides (CPPs) are mostly linear, hydrophobic, and short oligomers of
amino acids containing 5–30 residues that can permeate various substances through the …

Abstract Objective Pep-1 (CGEMGWVRC) can potently bind to interleukin 13 receptor α 2 (IL-
13Rα2), a tumor-restricted receptor found to be expressed in various malignancies. In this …

Accurate assessment of the HER2 expression is an essential issue for predicting response
to anti-HER2 therapy in breast cancer patients. The aim of this study was to evaluate 99m Tc …

While biomedical investigation has greatly advanced, investigators have lost touch with and
inadvertently corrupted significant nomenclature at the foundation of their science …

Background and purpose: The selection of co-ligand has a profound effect on the labeling
efficiency, biodistribution, and tumor-targeting ability of 99m Tc-labeled HYNIC-conjugated …

Introduction: Prostate-specific membrane antigen (PSMA) is increasingly recognized as a
viable target for imaging and therapy of Prostate cancer (PCa). In this study, we introduce …

Tumor-targeting peptides have been generally developed for the overexpression of tumor
specific receptors in cancer cells. The use of specific radiolabeled peptide allows tumor …